IS VISTA:VSIG3 AN ACTIONABLE IMMUNE CHECKPOINT TARGET IN KIDNEY CANCER?

$425,000FY2018Defense Health AgencyDOD

Dana-Farber Cancer Institute, Inc.

Investigators

View source on USAspending →